Elayne Kelen De Oliveira

Elayne Kelen De Oliveira

Auto-generated profile, based on publicly available information

Elayne Kelen De Oliveira

Cardiovascular Center Aalst, AZORG Hospital, Aalst, Belgium

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2009 in Brazilian Journal of Cardiovascular Surgery
Verified
Journal Article
Open access
PDF file
EOElayne Kelen de Oliveira
Elayne Kelen de Oliveira
VMVinicius Zacarias Maldaner
Vinicius Zacarias Maldaner
ATAída Luiza Ribeiro Turquetto
Aída Luiza Ribeiro Turquetto
The lung function is identified as a predictor of time of hospitalization in heart surgery. Meanwhile sixminute walk test has been used to establish functional capacity of cardiac patients, however there are few studies that correlate it with the length of hospital stay. The aim of this research was to determine whether there is correlation of preoperative and postoperative lung function and the ability of walking during the hospital stay. A prospective cohort with 18 patients was performed, being 8 males and 10 females, with age above 40 years (medium 64.89 +/- 6.95 years). Patients where admitted for coronary artery bypass graft surgery and/or exchange valve. To characterize the pulmonary function, patients were submitted to spirometry in preoperative and the 5th postoperative day. In the latter period was also a test for 6 minutes walk (6MWT) to characterize the ability to walk. There was not significant correlation of preoperative and postoperative pulmonary function with length of hospital stay. Only the distance covered in 6MWT showed a significant negative correlation (rho= 0.62) with length of stay. The distance in 6MWT obtained a significant positive correlation with forced vital capacity (r=0.59) and first second of a maximal forced expiratory manoeuvre (r=0.52). These results suggest that patients with increased postoperative capacity to walk have a shorter time of hospitalization and it also suggest that the distance in the 6MWT can better represent the functional capacity of these patients than pulmonary function alone.

2 October 2023 in Mayo Clinic Proceedings
Verified
Journal Article
Closed access
CCCristina De Colle
Cristina De Colle
Pasquale PaolissoPasquale Paolisso
Pasquale Paolisso
EGEmanuele Gallinoro
Emanuele Gallinoro
DBDario Tino Bertolone
Dario Tino Bertolone
NMNiya Mileva
Niya Mileva
MPMartin Penicka
Martin Penicka

1 July 2021 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
ONOtávio T Nóbrega
Otávio T Nóbrega
ACAlessandra M Campos-Staffico
Alessandra M Campos-Staffico
EOElayne Kelen Oliveira
Elayne Kelen Oliveira
DMDaniel Munhoz
Daniel Munhoz
FMFilipe A Moura
Filipe A Moura
ASAndrei C Sposito
Andrei C Sposito
Background: Glycemic disorders are strong predictors of mortality in ST-elevation myocardial infarction (STEMI) patients, and disruption in nitric oxide (NO) production is associated with insulin-resistant states. We evaluated whether a defective allele of the neuronal nitric oxide synthase (nNOS) gene (NOS1) might influence insulin response and blood-glucose balance during the acute phase of STEMI and if post-infarction total plasma-NO levels and vasodilation scores varied across nNOS genotypes. Methods: Consecutive patients with STEMI (n=354) underwent clinical evaluations and genotyping for the promoter variation rs41279104. In-hospital clinical and blood evaluations were performed at admission and five days after STEMI, with glycemic, insulinemic, and disposition indices assessed at the same times. Flow-mediated dilation (FMD) was assessed by reactive hyperemia on the 30th day. Results: Homozygotes for the defective allele (A) showed lower glycemia and insulin sensitivity on day 1 while showing the highest β-cell function and no changes in the circulating NO pool, which is compatible with hyperresponsive β cells counteracting the inherent glucose-resistant state of AA patients. At day 5, glycemic scores had shifted to indicate greater insulin sensitivity among A homozygotes, paralleled by a significant yet poor increase in NO bioavailability compared to that among G carriers. All in all, defective homozygotes showed greater insulin resistance at admission that had reversed by 5 days after STEMI. Even so, A carriers developed lower FMD scores compared to G homozygotes after the acute phase. Conclusion: A defective nNOS allele (and due decline in NO production) seemed to elicit a hyperinsulinemia response to compensate for an insulin-resistant state during the acute phase of STEMI and to be associated with poor endothelial function after the acute phase.

9 July 2026 in Open Heart
Verified
Journal Article
Open access
PDF file
RMRaffaella Mistrulli
Raffaella Mistrulli
MBMonika Beles
Monika Beles
EOElayne Kelen De Oliveira
Elayne Kelen De Oliveira
RVRosie Vrenozaj
Rosie Vrenozaj
SGSara Gharehdaghi
Sara Gharehdaghi
GCGuy Van Camp
Guy Van Camp
Background: Tricuspid regurgitation (TR) is a progressive and underdiagnosed condition associated with poor prognosis. Although the TRI-SCORE is a validated risk model for patients undergoing tricuspid valve surgery, it does not incorporate echocardiographic measures of right ventricular (RV) function or RV–pulmonary artery coupling, which are increasingly recognised as major prognostic determinants. Objectives: To evaluate whether integration of simple, widely available echocardiographic indices—tricuspid annular plane systolic excursion (TAPSE)/pulmonary artery systolic pressure (PASP), TAPSE/RV end-diastolic area (RVAD) and TAPSE/RV end-systolic area (RVAS)—improves the prognostic performance of the TRI-SCORE in patients with moderate-to-severe TR. Methods: We retrospectively included 93 patients with severe TR, including functional, mixed and primary/Cardiac Implantable Electronic Device (CIED)-related aetiologies treated with medical therapy, surgery or transcatheter edge-to-edge repair. The primary endpoint was all-cause mortality; the secondary endpoint was a composite of mortality or heart failure hospitalisation. Multivariable Cox regression models were used to assess the incremental predictive value of each TAPSE-derived ratio beyond the TRI-SCORE. Optimal thresholds were derived using spline regression and maximally selected rank statistics. Results: Lower TAPSE/PASP, TAPSE/RVAD and TAPSE/RVAS values were independently associated with worse outcomes. Each parameter significantly enhanced risk discrimination when added to the TRI-SCORE (C-index improved from 0.614 to 0.710 for TAPSE/PASP, 0.685 for TAPSE/RVAD and 0.696 for TAPSE/RVAS; all p<0.001). Prognostically relevant cut-offs were identified at 0.44, 0.80 and 1.3, respectively. Conclusions: Simple echocardiographic indices of RV function provide substantial incremental prognostic value when combined with the TRI-SCORE and may improve risk stratification and timing of intervention in isolated TR.